AI Verdict
HIMS has stronger fundamentals based on our AI analysis.
HIMS vs HHS Fundamental Comparison
| Metric | HIMS | HHS |
|---|---|---|
| Revenue | $2.3B | $159.6M |
| Net Income | $128.4M | $-811,000.0 |
| Net Margin | 5.5% | -0.5% |
| ROE | 23.7% | -4.0% |
| ROA | 6.0% | -0.9% |
| Current Ratio | 1.90x | 1.54x |
| Debt/Equity | 0.00x | 0.00x |
| EPS | $0.51 | $-0.11 |
Green = Better metric | Red = Weaker metric
You Might Also Compare
HIMS vs HHS: Frequently Asked Questions
Is HIMS or HHS a better buy in 2026?
Based on dual AI fundamental analysis (Claude and ChatGPT), HIMS has stronger fundamentals. HIMS is rated BUY (72% confidence) while HHS is rated STRONG SELL (88% confidence). This is not investment advice.
How does HIMS compare to HHS fundamentally?
Hims & Hers Health, Inc. has ROE of 23.7% vs HARTE HANKS INC's -4.0%. Net margins are 5.5% vs -0.5% respectively.
Which stock pays higher dividends, HIMS or HHS?
HIMS has a dividend yield of N/A or no dividend while HHS has N/A or no dividend. Check individual stock pages for detailed dividend history and payout ratios.
Should I invest in HIMS or HHS for long term?
For long-term investing, consider that HIMS has BUY rating with 72% confidence, while HHS has STRONG SELL rating with 88% confidence. Higher confidence indicates more consistent fundamentals from SEC filings. This is not investment advice - always do your own research.
What do the AI models say about HIMS vs HHS?
Our dual AI system (Claude by Anthropic and ChatGPT by OpenAI) analyzes SEC 10-K and 10-Q filings independently. For HIMS vs HHS, the AI consensus favors HIMS based on fundamental metrics including revenue growth, profitability, ROE, and balance sheet strength.